Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis

Sulfonylurea is one of the commonly used anti-diabetic drugs that stimulate insulin secretion from β-cells. Despite their glucose lowering effects in type 2 diabetes mellitus, long-term treatment brought on secondary failure characterized by β-cell exhaustion and apoptosis. ER stress induced by Ca2+...

Full description

Bibliographic Details
Main Authors: Ju-Young Kim, Dong-Mee Lim, Hyung-Seo Park, Chan-Il Moon, Kyung-Jin Choi, Seong-Kyu Lee, Haing-Woon Baik, Keun-Young Park, Byung-Joon Kim
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861319305997
_version_ 1811231016004616192
author Ju-Young Kim
Dong-Mee Lim
Hyung-Seo Park
Chan-Il Moon
Kyung-Jin Choi
Seong-Kyu Lee
Haing-Woon Baik
Keun-Young Park
Byung-Joon Kim
author_facet Ju-Young Kim
Dong-Mee Lim
Hyung-Seo Park
Chan-Il Moon
Kyung-Jin Choi
Seong-Kyu Lee
Haing-Woon Baik
Keun-Young Park
Byung-Joon Kim
author_sort Ju-Young Kim
collection DOAJ
description Sulfonylurea is one of the commonly used anti-diabetic drugs that stimulate insulin secretion from β-cells. Despite their glucose lowering effects in type 2 diabetes mellitus, long-term treatment brought on secondary failure characterized by β-cell exhaustion and apoptosis. ER stress induced by Ca2+ depletion in endoplasmic reticulum (ER) is speculated be one of the causes of secondary failure, but it remains unclear. Glucagon like peptide-1 (GLP-1) has anti-apoptotic effects in β-cells after the induction of oxidative and ER stress. In this study, we examined the antiapoptotic action of a GLP-1 analogue in β-cell lines and islets against ER stress induced by chronic treatment of sulfonylurea. HIT-T15 and dispersed islet cells were exposed to glibenclamide for 48 h, and apoptosis was evaluated using Annexin/PI flow cytometry. Expression of the ER stress–related molecules and sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 2/3 was determined by real-time PCR and western blot analysis. Chronic exposure to glibenclamide increased apoptosis by depletion of ER Ca2+ concentration through reduced expression of SERCA 2/3. Pretreatment with Exendin-4 had an anti-apoptotic role through ER stress modulation and ER Ca2+ replenishing by SERCA restoration. These findings will further the understanding of one cause of glibenclamide-induced β-cell loss and therapeutic availability of GLP-1–based drugs in secondary failure by sulfonylurea during treatment of diabetes. Keywords:: endoplasmic reticulum (ER) calcium depletion, apoptosis, ER stress, glucagon like peptide-1(GLP-1), sulfonylurea
first_indexed 2024-04-12T10:39:03Z
format Article
id doaj.art-3e8613daa9944238a7651a143a9b9071
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-04-12T10:39:03Z
publishDate 2012-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-3e8613daa9944238a7651a143a9b90712022-12-22T03:36:39ZengElsevierJournal of Pharmacological Sciences1347-86132012-01-0111816574Exendin-4 Protects Against Sulfonylurea-Induced β-Cell ApoptosisJu-Young Kim0Dong-Mee Lim1Hyung-Seo Park2Chan-Il Moon3Kyung-Jin Choi4Seong-Kyu Lee5Haing-Woon Baik6Keun-Young Park7Byung-Joon Kim8Division of Endocrinology and Metabolism, Department of Internal Medicine, Daejeon 302-832, KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Daejeon 302-832, KoreaDepartment of Physiology, Konyang University School of Medicine, Daejeon 302-832, KoreaDepartment of Cardiology, Gachon University of Medicine and Science, Incheon 406-799, KoreaDepartment of Physiology, Konyang University School of Medicine, Daejeon 302-832, KoreaDepartment of Biochemistry and Molecular Biology, Eulji University School of Medicine, Daejeon 301-746, KoreaDepartment of Biochemistry and Molecular Biology, Eulji University School of Medicine, Daejeon 301-746, KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Daejeon 302-832, KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Daejeon 302-832, Korea; Myunggok Medical Research Institute, Konyang University School of Medicine, Daejeon 302-832, Korea; Corresponding author. kbjoon4u@hananet.netSulfonylurea is one of the commonly used anti-diabetic drugs that stimulate insulin secretion from β-cells. Despite their glucose lowering effects in type 2 diabetes mellitus, long-term treatment brought on secondary failure characterized by β-cell exhaustion and apoptosis. ER stress induced by Ca2+ depletion in endoplasmic reticulum (ER) is speculated be one of the causes of secondary failure, but it remains unclear. Glucagon like peptide-1 (GLP-1) has anti-apoptotic effects in β-cells after the induction of oxidative and ER stress. In this study, we examined the antiapoptotic action of a GLP-1 analogue in β-cell lines and islets against ER stress induced by chronic treatment of sulfonylurea. HIT-T15 and dispersed islet cells were exposed to glibenclamide for 48 h, and apoptosis was evaluated using Annexin/PI flow cytometry. Expression of the ER stress–related molecules and sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 2/3 was determined by real-time PCR and western blot analysis. Chronic exposure to glibenclamide increased apoptosis by depletion of ER Ca2+ concentration through reduced expression of SERCA 2/3. Pretreatment with Exendin-4 had an anti-apoptotic role through ER stress modulation and ER Ca2+ replenishing by SERCA restoration. These findings will further the understanding of one cause of glibenclamide-induced β-cell loss and therapeutic availability of GLP-1–based drugs in secondary failure by sulfonylurea during treatment of diabetes. Keywords:: endoplasmic reticulum (ER) calcium depletion, apoptosis, ER stress, glucagon like peptide-1(GLP-1), sulfonylureahttp://www.sciencedirect.com/science/article/pii/S1347861319305997
spellingShingle Ju-Young Kim
Dong-Mee Lim
Hyung-Seo Park
Chan-Il Moon
Kyung-Jin Choi
Seong-Kyu Lee
Haing-Woon Baik
Keun-Young Park
Byung-Joon Kim
Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
Journal of Pharmacological Sciences
title Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
title_full Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
title_fullStr Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
title_full_unstemmed Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
title_short Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
title_sort exendin 4 protects against sulfonylurea induced β cell apoptosis
url http://www.sciencedirect.com/science/article/pii/S1347861319305997
work_keys_str_mv AT juyoungkim exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT dongmeelim exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT hyungseopark exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT chanilmoon exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT kyungjinchoi exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT seongkyulee exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT haingwoonbaik exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT keunyoungpark exendin4protectsagainstsulfonylureainducedbcellapoptosis
AT byungjoonkim exendin4protectsagainstsulfonylureainducedbcellapoptosis